Health Canada drug identification number

DIN 02246081 — VARIVAX III 1350 UNIT

VARIVAX III is a powder for solution of Varicella Virus Live Attenuated marketed by MERCK CANADA INC. The full Varicella Virus Live Attenuated monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02246081
Brand name
VARIVAX III
Strength
1350 UNIT
Dosage form
POWDER FOR SOLUTION
Route
INTRAMUSCULAR; SUBCUTANEOUS
Manufacturer
MERCK CANADA INC
Health Canada status
MARKETED
Drug class
Live attenuated viral vaccine (active immunizing agent against varicella)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.